Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Apr 15;291(Pt 2):615–622. doi: 10.1042/bj2910615

Inhibitory effect of fluoride on insulin receptor autophosphorylation and tyrosine kinase activity.

F Viñals 1, X Testar 1, M Palacín 1, A Zorzano 1
PMCID: PMC1132568  PMID: 7683457

Abstract

Fluoride is a nucleophilic reagent which has been reported to inhibit a variety of different enzymes such as esterases, asymmetrical hydrolases and phosphatases. In this report, we demonstrate that fluoride inhibits tyrosine kinase activity of insulin receptors partially purified from rat skeletal muscle and human placenta. Fluoride inhibited in a similar dose-dependent manner both beta-subunit autophosphorylation and tyrosine kinase activity for exogenous substrates. This inhibitory effect of fluoride was not due to the formation of complexes with aluminum and took place in the absence of modifications of insulin-binding properties of the insulin receptor. Fluoride did not complete with the binding site for ATP or Mn2+. Fluoride also inhibited the autophosphorylation and tyrosine kinase activity of receptors for insulin-like growth factor I from human placenta. Addition of fluoride to the pre-phosphorylated insulin receptor produced a slow (time range of minutes) inhibition of receptor kinase activity. Furthermore, fluoride inhibited tyrosine kinase activity in the absence of changes in the phosphorylation of prephosphorylated insulin receptors, and the sensitivity to fluoride was similar to the sensitivity of the unphosphorylated insulin receptor. The effect of fluoride-on tyrosine kinase activity was markedly decreased when insulin receptors were preincubated with the copolymer of glutamate/tyrosine. Prior exposure of receptors to free tyrosine or phosphotyrosine also prevented the inhibitory effect of fluoride. However, the protective effect of tyrosine or phosphotyrosine was maximal at low concentrations, suggesting the interaction of these compounds with the receptor itself rather than with fluoride. These data suggest: (i) that fluoride interacts directly and slowly with the insulin receptor, which causes inhibition of its phosphotransferase activity; (ii) that the binding site of fluoride is not structurally modified by receptor phosphorylation; and (iii) based on the fact that fluoride inhibits phosphotransferase activity in the absence of alterations in the binding of ATP, Mn2+ or insulin, we speculate that fluoride binding might affect the transfer of phosphate from ATP to the tyrosine residues of the beta-subunit of the insulin receptor and to the tyrosine residues of exogenous substrates.

Full text

PDF
615

Images in this article

617Figure 2
on p.617
618Figure 3
on p.618
619Figure 6
on p.619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron V., Gautier N., Komoriya A., Hainaut P., Scimeca J. C., Mervic M., Lavielle S., Dolais-Kitabgi J., Van Obberghen E. Insulin binding to its receptor induces a conformational change in the receptor C-terminus. Biochemistry. 1990 May 15;29(19):4634–4641. doi: 10.1021/bi00471a019. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Bunick F. J., Kashket S. Binding of fluoride by yeast enolase. Biochemistry. 1982 Aug 31;21(18):4285–4290. doi: 10.1021/bi00261a017. [DOI] [PubMed] [Google Scholar]
  4. Camps M., Gumà A., Testar X., Palacín M., Zorzano A. Insulin resistance of skeletal muscle during pregnancy is not a consequence of intrinsic modifications of insulin receptor binding or kinase activities. Endocrinology. 1990 Nov;127(5):2561–2570. doi: 10.1210/endo-127-5-2561. [DOI] [PubMed] [Google Scholar]
  5. Chabre M. Aluminofluoride and beryllofluoride complexes: a new phosphate analogs in enzymology. Trends Biochem Sci. 1990 Jan;15(1):6–10. doi: 10.1016/0968-0004(90)90117-t. [DOI] [PubMed] [Google Scholar]
  6. Chou C. K., Dull T. J., Russell D. S., Gherzi R., Lebwohl D., Ullrich A., Rosen O. M. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem. 1987 Feb 5;262(4):1842–1847. [PubMed] [Google Scholar]
  7. De Meyts P., Gu J. L., Shymko R. M., Kaplan B. E., Bell G. I., Whittaker J. Identification of a ligand-binding region of the human insulin receptor encoded by the second exon of the gene. Mol Endocrinol. 1990 Mar;4(3):409–416. doi: 10.1210/mend-4-3-409. [DOI] [PubMed] [Google Scholar]
  8. Debant A., Clauser E., Ponzio G., Filloux C., Auzan C., Contreres J. O., Rossi B. Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8032–8036. doi: 10.1073/pnas.85.21.8032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ebina Y., Araki E., Taira M., Shimada F., Mori M., Craik C. S., Siddle K., Pierce S. B., Roth R. A., Rutter W. J. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A. 1987 Feb;84(3):704–708. doi: 10.1073/pnas.84.3.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Ou J. H., Masiarz F., Kan Y. W., Goldfine I. D. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 1985 Apr;40(4):747–758. doi: 10.1016/0092-8674(85)90334-4. [DOI] [PubMed] [Google Scholar]
  11. Ellis L., Clauser E., Morgan D. O., Edery M., Roth R. A., Rutter W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell. 1986 Jun 6;45(5):721–732. doi: 10.1016/0092-8674(86)90786-5. [DOI] [PubMed] [Google Scholar]
  12. Ellis L., Morgan D. O., Clauser E., Roth R. A., Rutter W. J. A membrane-anchored cytoplasmic domain of the human insulin receptor mediates a constitutively elevated insulin-independent uptake of 2-deoxyglucose. Mol Endocrinol. 1987 Jan;1(1):15–24. doi: 10.1210/mend-1-1-15. [DOI] [PubMed] [Google Scholar]
  13. Flores-Riveros J. R., Sibley E., Kastelic T., Lane M. D. Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J Biol Chem. 1989 Dec 25;264(36):21557–21572. [PubMed] [Google Scholar]
  14. Goren H. J., White M. F., Kahn C. R. Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity. Biochemistry. 1987 Apr 21;26(8):2374–2382. doi: 10.1021/bi00382a044. [DOI] [PubMed] [Google Scholar]
  15. Harrison L. C., Itin A. Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody. J Biol Chem. 1980 Dec 25;255(24):12066–12072. [PubMed] [Google Scholar]
  16. Herrera R., Rosen O. M. Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation. J Biol Chem. 1986 Sep 15;261(26):11980–11985. [PubMed] [Google Scholar]
  17. James D. E., Zorzano A., Böni-Schnetzler M., Nemenoff R. A., Powers A., Pilch P. F., Ruderman N. B. Intrinsic differences of insulin receptor kinase activity in red and white muscle. J Biol Chem. 1986 Nov 15;261(32):14939–14944. [PubMed] [Google Scholar]
  18. Kasuga M., Karlsson F. A., Kahn C. R. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science. 1982 Jan 8;215(4529):185–187. doi: 10.1126/science.7031900. [DOI] [PubMed] [Google Scholar]
  19. Kasuga M., Zick Y., Blith D. L., Karlsson F. A., Häring H. U., Kahn C. R. Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. J Biol Chem. 1982 Sep 10;257(17):9891–9894. [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Layne P. P., Najjar V. A. The dephosphorylation of phosphoglucomutase by nucleophilic reagents. J Biol Chem. 1975 Feb 10;250(3):966–972. [PubMed] [Google Scholar]
  22. Maller J. L., Pike L. J., Freidenberg G. R., Cordera R., Stith B. J., Olefsky J. M., Krebs E. G. Increased phosphorylation of ribosomal protein S6 following microinjection of insulin receptor-kinase into Xenopus oocytes. Nature. 1986 Apr 3;320(6061):459–461. doi: 10.1038/320459a0. [DOI] [PubMed] [Google Scholar]
  23. Massague J., Pilch P. F., Czech M. P. Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7137–7141. doi: 10.1073/pnas.77.12.7137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Massagué J., Czech M. P. Role of disulfides in the subunit structure of the insulin receptor. Reduction of class I disulfides does not impair transmembrane signalling. J Biol Chem. 1982 Jun 25;257(12):6729–6738. [PubMed] [Google Scholar]
  25. McClain D. A., Maegawa H., Lee J., Dull T. J., Ulrich A., Olefsky J. M. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem. 1987 Oct 25;262(30):14663–14671. [PubMed] [Google Scholar]
  26. Morgan D. O., Ho L., Korn L. J., Roth R. A. Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A. 1986 Jan;83(2):328–332. doi: 10.1073/pnas.83.2.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Morgan D. O., Roth R. A. Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin. Proc Natl Acad Sci U S A. 1987 Jan;84(1):41–45. doi: 10.1073/pnas.84.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Murphy A. J., Coll R. J. Fluoride is a slow, tight-binding inhibitor of the calcium ATPase of sarcoplasmic reticulum. J Biol Chem. 1992 Mar 15;267(8):5229–5235. [PubMed] [Google Scholar]
  29. Nilsson T., Brändén R. Kinetic study of the interaction between ribulosebisphosphate carboxylase/oxygenase and inorganic fluoride. Biochemistry. 1983 Mar 29;22(7):1641–1645. doi: 10.1021/bi00276a018. [DOI] [PubMed] [Google Scholar]
  30. Perlman R., Bottaro D. P., White M. F., Kahn C. R. Conformational changes in the alpha- and beta-subunits of the insulin receptor identified by anti-peptide antibodies. J Biol Chem. 1989 May 25;264(15):8946–8950. [PubMed] [Google Scholar]
  31. Petruzzelli L., Herrera R., Rosen O. M. Insulin receptor is an insulin-dependent tyrosine protein kinase: copurification of insulin-binding activity and protein kinase activity to homogeneity from human placenta. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3327–3331. doi: 10.1073/pnas.81.11.3327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rosen O. M., Herrera R., Olowe Y., Petruzzelli L. M., Cobb M. H. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3237–3240. doi: 10.1073/pnas.80.11.3237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rubin J. B., Shia M. A., Pilch P. F. Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I. 1983 Sep 29-Oct 5Nature. 305(5933):438–440. doi: 10.1038/305438a0. [DOI] [PubMed] [Google Scholar]
  34. Sasaki N., Rees-Jones R. W., Zick Y., Nissley S. P., Rechler M. M. Characterization of insulin-like growth factor I-stimulated tyrosine kinase activity associated with the beta-subunit of type I insulin-like growth factor receptors of rat liver cells. J Biol Chem. 1985 Aug 15;260(17):9793–9804. [PubMed] [Google Scholar]
  35. Shia M. A., Pilch P. F. The beta subunit of the insulin receptor is an insulin-activated protein kinase. Biochemistry. 1983 Feb 15;22(4):717–721. doi: 10.1021/bi00273a001. [DOI] [PubMed] [Google Scholar]
  36. Shoelson S. E., White M. F., Kahn C. R. Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. J Biol Chem. 1988 Apr 5;263(10):4852–4860. [PubMed] [Google Scholar]
  37. Tavaré J. M., Denton R. M. Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping. Biochem J. 1988 Jun 1;252(2):607–615. doi: 10.1042/bj2520607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tavaré J. M., O'Brien R. M., Siddle K., Denton R. M. Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. Biochem J. 1988 Aug 1;253(3):783–788. doi: 10.1042/bj2530783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tornqvist H. E., Gunsalus J. R., Nemenoff R. A., Frackelton A. R., Pierce M. W., Avruch J. Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells. J Biol Chem. 1988 Jan 5;263(1):350–359. [PubMed] [Google Scholar]
  40. Tornqvist H. E., Pierce M. W., Frackelton A. R., Nemenoff R. A., Avruch J. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem. 1987 Jul 25;262(21):10212–10219. [PubMed] [Google Scholar]
  41. Ullrich A., Bell J. R., Chen E. Y., Herrera R., Petruzzelli L. M., Dull T. J., Gray A., Coussens L., Liao Y. C., Tsubokawa M. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. 1985 Feb 28-Mar 6Nature. 313(6005):756–761. doi: 10.1038/313756a0. [DOI] [PubMed] [Google Scholar]
  42. Waugh S. M., DiBella E. E., Pilch P. F. Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding. Biochemistry. 1989 Apr 18;28(8):3448–3455. doi: 10.1021/bi00434a045. [DOI] [PubMed] [Google Scholar]
  43. Waugh S. M., Pilch P. F. Insulin binding changes the interface region between alpha subunits of the insulin receptor. Biochemistry. 1989 Mar 21;28(6):2722–2727. doi: 10.1021/bi00432a053. [DOI] [PubMed] [Google Scholar]
  44. White M. F., Shoelson S. E., Keutmann H., Kahn C. R. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem. 1988 Feb 25;263(6):2969–2980. [PubMed] [Google Scholar]
  45. White M. F., Takayama S., Kahn C. R. Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro. J Biol Chem. 1985 Aug 5;260(16):9470–9478. [PubMed] [Google Scholar]
  46. Yip C. C., Hsu H., Patel R. G., Hawley D. M., Maddux B. A., Goldfine I. D. Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit. Biochem Biophys Res Commun. 1988 Nov 30;157(1):321–329. doi: 10.1016/s0006-291x(88)80050-0. [DOI] [PubMed] [Google Scholar]
  47. Yu K. T., Czech M. P. Tyrosine phosphorylation of the insulin receptor beta subunit activates the receptor-associated tyrosine kinase activity. J Biol Chem. 1984 Apr 25;259(8):5277–5286. [PubMed] [Google Scholar]
  48. Zhang B., Tavaré J. M., Ellis L., Roth R. A. The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J Biol Chem. 1991 Jan 15;266(2):990–996. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES